PACTR202407803149023Not yet recruitingPhase 3
Clinical evaluation of Malaria rapid diagnostic test kits
SD Biosensor0 sites2,000 target enrollmentStarted: July 12, 2024Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 2,000
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 1 Month(s) to 23 Month(s) (—)
- Sex
- All
Inclusion Criteria
- •Presenting at the study site with fever or a history of fever during the preceding 48-hours
- •Freely agreeing to participate by providing informed consent (and assent, as applicable
Exclusion Criteria
- •Presence of symptoms and signs of severe illness and/or central nervous system infections as defined by WHO guidelines.
Investigators
Similar Trials
Completed
Phase 4
Trial of Rapid Diagnostic Tests in Rural GhanaBacterial InfectionsMalariaNCT00493922London School of Hygiene and Tropical Medicine7,263
Not yet recruiting
Not Applicable
Evaluation of Malaria Detection Function Leveraging New Products in ThailandMalariaTCTR20191017002ational Center for Global Health and Medicine (NCGM)350
Completed
Not Applicable
Use of Rapid Diagnostic Tests for Malaria Case Management in KenyaMalariaNCT00336388Centers for Disease Control and Prevention3,600
Completed
Phase 4
Efficacy and Cost Effectiveness of Malaria Diagnosis Procedures and the Rational Use of ACT in ZanzibarMalariaNCT00549003Karolinska University Hospital9,346
Completed
Phase 4
The Role of Rapid Diagnostic Tests for Malaria for Targeting of ACTs at Community LevelMalariaNCT01907672Ghana Health Services4,748